欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4569/001
药品名称Ondansetron Accord 2 mg/ml,
活性成分
    • ondansetron dihydrochloride 2.0 mg/ml
剂型Solution for injection/infusion
上市许可持有人Accord Healthcare B.V. Winthontlaan 200 3526 KV Utrecht The Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Germany (DE)
      Ondasetron Accord 2mg/mL Injektionslösung
    • Denmark (DK)
    • Belgium (BE)
    • Ireland (IE)
    • Austria (AT)
      Ondansetron Accord 2 mg/ml Injektions- oder Infusionslösung
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
      Ondansetron Accord
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Ondansetron Accord 2 mg/ml
    • Latvia (LV)
      Ondansetron Accord 2 mg/ml šķīdums injekcijām vai infūzijām
    • Estonia (EE)
    • Cyprus (CY)
      ONDANSETRON ACCORD 2MG/ML
    • Slovakia (SK)
      Ondasetron Accord 2mg/mL, injekčný roztok
    • Slovenia (SI)
    • Malta (MT)
      Ondansetron Accord Solution for injection 2mg/ml
    • Lithuania (LT)
      Ondansetron Accord 2 mg/ml injekcinis / infuzinis tirpalas
    • Czechia (CZ)
    • Bulgaria (BG)
许可日期2009/11/06
最近更新日期2024/03/07
药物ATC编码
    • A04AA01 ondansetron
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase